Pharmacy Regulator instructs pharmacists to alert patients to valproate risks
The Pharmaceutical Society of Ireland has today issued instructions to all pharmacists that they must inform women of child-bearing age of the potential risk of abnormal pregnancy outcomes when supplying sodium valproate (Epilim). This includes providing counselling and including a Package Leaflet and Alert Card with each supply of the drug.
The new directive comes after the European Medicines Agency's recent recommendations on risk minimisation.